Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Treasury Stock Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020				51,679,516
Beginning balance at Dec. 31, 2020		$ 624,428		$ 523		$ (6,061)		$ 522,911		$ 77,652		$ 29,403
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		48,612		0		0		0		48,612		0
Other comprehensive loss		(9,497)		$ 0		0		0		0		(9,497)
Issuance of shares from equity-based awards (in shares)				287,375
Issuance of shares from equity-based awards		(605)		$ 3		0		(608)		0		0
Open market common share repurchases		(13,939)		$ 0		(13,939)		0		0		0
Open market common share repurchases (in shares)				(964,193)
Employee receivables from sale of stock		35		$ 0		0		0		35		0
Stock-based compensation		3,373		$ 0		0		3,373		0		0
Ending balance (in shares) at Sep. 30, 2021				51,002,698
Ending balance at Sep. 30, 2021		652,407		$ 526		(20,000)		525,676		126,299		19,906
Beginning balance (in shares) at Jun. 30, 2021				50,958,680
Beginning balance at Jun. 30, 2021		637,190		$ 525		(20,000)		524,637		105,299		26,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		21,000		0		0		0		21,000		0
Other comprehensive loss		(6,823)		$ 0		0		0		0		(6,823)
Issuance of shares from equity-based awards (in shares)				44,018
Issuance of shares from equity-based awards		(109)		$ 1		0		(110)		0		0
Stock-based compensation		1,149		$ 0		0		1,149		0		0
Ending balance (in shares) at Sep. 30, 2021				51,002,698
Ending balance at Sep. 30, 2021		$ 652,407		$ 526		(20,000)		525,676		126,299		19,906
Beginning balance (in shares) at Dec. 31, 2021		52,590,015		50,450,045
Beginning balance at Dec. 31, 2021		$ 667,573		$ 526		(28,347)		526,806		147,099		21,489
Beginning balance (ASU 2016-13 [Member]) at Dec. 31, 2021	[1]		$ (2,610)		$ 0		$ 0		$ 0		$ (2,610)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		49,653		0		0		0		49,653		0
Other comprehensive loss		(105,938)		$ 0		0		0		0		(105,938)
Issuance of shares from equity-based awards (in shares)				394,933
Issuance of shares from equity-based awards		(627)		$ 4		0		(631)		0		0
Open market common share repurchases		(30,981)		$ 0		(30,981)		0		0		0
Open market common share repurchases (in shares)				(2,090,782)
Employee receivables from sale of stock		6		$ 0		0		0		6		0
Stock-based compensation		3,304		$ 0		0		3,304		0		0
Exercise of warrants (in shares)				33,500
Exercise of warrants		$ 167		$ 0		0		167		0		0
Ending balance (in shares) at Sep. 30, 2022		53,018,448		48,787,696
Ending balance at Sep. 30, 2022		$ 580,547		$ 530		(59,328)		529,646		194,148		(84,449)
Beginning balance (in shares) at Jun. 30, 2022				49,535,949
Beginning balance at Jun. 30, 2022		608,015		$ 529		(48,501)		528,548		176,868		(49,429)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income		17,280		0		0		0		17,280		0
Other comprehensive loss		(35,020)		$ 0		0		0		0		(35,020)
Issuance of shares from equity-based awards (in shares)				46,204
Issuance of shares from equity-based awards		30		$ 1		0		29		0		0
Open market common share repurchases		(10,827)		$ 0		(10,827)		0		0		0
Open market common share repurchases (in shares)				(794,457)
Stock-based compensation		$ 1,069		$ 0		0		1,069		0		0
Ending balance (in shares) at Sep. 30, 2022		53,018,448		48,787,696
Ending balance at Sep. 30, 2022		$ 580,547		$ 530		$ (59,328)		$ 529,646		$ 194,148		$ (84,449)

[1] (1)   Includes the impact of implementing Accounting Standards Update (“ASU”)   2016-13, Financial Instruments - Credit Losses (Accounting Standard Codification   (“ASC”) 326): Measurement of Credit Losses on Financial Instruments.   See “Note 1: Nature of Operations and Summary of Significant Accounting   Policies” in the Notes to Condensed Consolidated Financial Statements (unaudited) for more information on the   Company’s adoption of this guidance   and the impact to the Company’s   results of operations.